ANN ARBOR – The University of Michigan plans to have about 1,700 employees at the ex-Pfizer site in northern Ann Arbor by the end of 2012, according to projections reported by AnnArbor.Com.
David Canter, who led the Pfizer site in northern Ann Arbor when the global pharmaceutical company owned it, is executive director of the complex for the University of Michigan.
U-M, which bought the 174-acre former Pfizer property in 2009, had about 830 employees working at the 30-building campus at the end of September.
Among the groups that have already moved to the site are health care researchers, technology transfer operations, business engagement activities and some Comprehensive Cancer Center employees.
The university expects to have about 1,000 employees at the site by the end of 2011, up from 466 a year earlier, according to the newsletter.
The employees expected to move to the Pfizer campus next are cardiovascular researchers, according to the newsletter. U-M said in May that it would move about 60 cardiovascular scientists to high-tech laboratories at the Pfizer site, forming a “a cardiovascular research cluster.”
When it bought the ex-Pfizer site for $108 million, U-M announced it would staff the campus with 2,000 to 3,000 employees within 10 years.
So far, about 150 of the 830 workers at the site are new hires, U-M Health System CEO Ora Pescovitz said last month.
Meanwhile, a U-M startup biotech company called Lycera Corp. is moving this month to 14,000 square feet of leased space at one of the Pfizer labs.
That comes as the U-M Technology Transfer Office’s new business incubator, called the Venture Accelerator, is filling up with early-stage startups led by U-M faculty.
a>>
